Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer
For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new research.
Have you thought about signing up to the NIHR BioResource as a healthy volunteer?
As far as clinical research is concerned, it could be one of the best things you ever do!
When Read more
The NIHR Cambridge BRC is offering all research staff a training session on Patient and Public Involvement.
The half-day session will provide staff with an introduction to Patient and Public Involvement (PPI) Read more
Regularly drinking more than the recommended UK guidelines for alcohol could take years off your life, according to new research from the University of Cambridge. Part-funded by the British Heart Read more
Scientists say they have identified genes that cause a deadly heart condition – pulmonary arterial hypertension (PAH) – that can only be cured by transplants of the heart or lungs.
Pulmonary Arterial Hypertension Read more
A platform for research into Crohn’s Disease and Ulcerative Colitis has now signed up 10,000 participants nationwide.
The National Institute for Health Research (NIHR) IBD BioResource was established in 2016 by the Read more
Put motivated people together and you can expect a lot of questions and debate. And that’s what happened when 150 people representing more than 70 rare diseases travelled from all corners of England Read more
Following the high demand last year, the eHospital Research Design Authority has arranged another two Epic research seminars for research staff who actively use the Epic system at CUH.
These sessions will give Read more